miR-199a Links MeCP2 with mTOR Signaling and Its Dysregulation Leads to Rett Syndrome Phenotypes
2015 · Cell Reports · 114 citations
https://doi.org/10.1016/j.celrep.2015.08.028
H
Hideyuki Nakashima
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
81
Papers
2.0K
Citations
23
h-index
38
i10-index
Hideyuki Nakashima is an academic researcher from Kyushu University. The author has contributed to research in topics: Head and Neck Cancer Studies & Genetics and Neurodevelopmental Disorders & Toxin Mechanisms and Immunotoxins. The author has an h-index of 23, co-authored 69 publications.
ORCID: 0000-0001-9430-5363Papers by this author
worksSimultaneous hyperthermia-chemotherapy with controlled drug delivery using single-drug nanoparticles
2016 · Scientific Reports · 79 citations
https://doi.org/10.1038/srep24629
Functional Activation of Src Family Kinase Yes Protein Is Essential for the Enhanced Malignant Properties of Human Melanoma Cells Expressing Ganglioside GD3
2011 · Journal of Biological Chemistry · 75 citations
https://doi.org/10.1074/jbc.m110.164798
Overexpression of caveolin‐1 in a human melanoma cell line results in dispersion of ganglioside GD3 from lipid rafts and alteration of leading edges, leading to attenuation of malignant properties
2007 · Cancer Science · 51 citations
https://doi.org/10.1111/j.1349-7006.2007.00419.x
Focal adhesion kinase as well as p130Cas and paxillin is crucially involved in the enhanced malignant properties under expression of ganglioside GD3 in melanoma cells
2007 · Biochimica et Biophysica Acta (BBA) - General Subjects · 49 citations
https://doi.org/10.1016/j.bbagen.2007.11.002
MeCP2 controls neural stem cell fate specification through miR-199a-mediated inhibition of BMP-Smad signaling
2021 · Cell Reports · 49 citations
https://doi.org/10.1016/j.celrep.2021.109124
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat